Frontlight ResearchEarly access
Trial site
National Cancer Institute
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- BeiGene1 trial
- Cantargia AB1 trial
- European Association of Urology Research Foundation1 trial
- European Institute of Oncology1 trial
- Hoffmann-La Roche1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Enrolling by invitation
Prostate Cancer Awareness and Initiative for Screening in the European Union
Active, not recruiting
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
Site data: ClinicalTrials.govUpdated 14 Nov 2026